EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Encapsulation and controlled release of 1,4-naphthoquinone in PDLA nanoparticles: design, biological efficacy, and cancer targeting

Karina González, Edgar Del Carpio, Gema González, María Luisa Serrano, Jorge Vicente Lopes Da Silva, Marcos Sabino

International Journal of Advances in Medical Biotechnology - IJAMB · 01.12.2024 · 6 (2) · 22-37

DOI: 10.52466/ijamb.v6i2.128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Advances in Medical Biotechnology - IJAMB, online erschienen am 01.12.2024. Verfasst von Karina González und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug release can be controlled by encapsulating active compounds in polymeric vehicles. Using nanotechnology, pharmaceutical drug delivery systems can be controlled and precise. The aim of this work is to obtain and characterize biocompatible micro and nanoparticulate systems based on a poly(D-lactic acid) matrix (PDLA) to study the controlled release of 1,4-naphthoquinone, which has reported anticancer activity. Scanning electron microscopy revealed spherical particles with an average size of 347 nm and 86% in the nanometer range. The encapsulation efficiency was 98.3%, as assessed by UV-visible spectroscopy. The hydrolytic degradation over 11 weeks showed controlled release of naphthoquinone at different pH conditions: 20.98% in alkaline, 19.69% in physiological, 18.83% in strongly acidic, and 16.70% in slightly acidic conditions. The enhanced release at alkaline pH suggests potential anticancer activity in colorectal cancer, benefiting treatment by releasing the drug to the affected area. Molecular docking studies on COX-2 confirmed these results, showing 1,4-naphthoquinone interacts with key amino acids (ALA202, THR206, HIS207) in the active site, modifying the prostaglandin chain which is crucial for the enzyme's function. The results show that this system has a high potentiality for use for pharmacological applications in colorectal cancer, as 1,4-naphthoquinone exhibits electronic properties.

Zitieren

APA

González, K., Carpio, E. D., González, G., Serrano, M. L., Silva, J. V. L. D., & Sabino, M. (2024). Encapsulation and controlled release of 1,4-naphthoquinone in PDLA nanoparticles: design, biological efficacy, and cancer targeting. International Journal of Advances in Medical Biotechnology - IJAMB, 6(2), 22-37. https://doi.org/10.52466/ijamb.v6i2.128

Vancouver

González K, Carpio ED, González G, Serrano ML, Silva JVLD, Sabino M. Encapsulation and controlled release of 1,4-naphthoquinone in PDLA nanoparticles: design, biological efficacy, and cancer targeting. International Journal of Advances in Medical Biotechnology - IJAMB. 2024;6(2):22-37. doi:10.52466/ijamb.v6i2.128

BibTeX
@article{Gonzlez2024,
  author = {González, Karina and Carpio, Edgar Del and González, Gema and Serrano, María Luisa and Silva, Jorge Vicente Lopes Da and Sabino, Marcos},
  title = {Encapsulation and controlled release of 1,4-naphthoquinone in PDLA nanoparticles: design, biological efficacy, and cancer targeting},
  journal = {International Journal of Advances in Medical Biotechnology - IJAMB},
  year = {2024},
  volume = {6},
  number = {2},
  pages = {22--37},
  doi = {10.52466/ijamb.v6i2.128}
}
Kostenlos starten →